1 Market Overview

• 1.1 Product Overview and Scope
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Market Analysis by Type
  • 1.3.1 Overview: Global Masiroxavir Tablets Consumption Value by Type: 2021 Versus 2025 Versus 2032
  • 1.3.2 20 mg per tablet
  • 1.3.3 40 mg per tablet
• 1.4 Market Analysis by Target Population
  • 1.4.1 Overview: Global Masiroxavir Tablets Consumption Value by Target Population: 2021 Versus 2025 Versus 2032
  • 1.4.2 Patients Aged 12 Years And Older With Influenza A
  • 1.4.3 Patients Aged 12 Years And Older With Influenza B
• 1.5 Market Analysis by Sales Channels
  • 1.5.1 Overview: Global Masiroxavir Tablets Consumption Value by Sales Channels: 2021 Versus 2025 Versus 2032
  • 1.5.2 Hospital
  • 1.5.3 Retail
  • 1.5.4 Online
• 1.6 Market Analysis by Production Technology
  • 1.6.1 Overview: Global Masiroxavir Tablets Consumption Value by Production Technology: 2021 Versus 2025 Versus 2032
  • 1.6.2 Innovator
  • 1.6.3 Generic
• 1.7 Market Analysis by Application
  • 1.7.1 Overview: Global Masiroxavir Tablets Consumption Value by Application: 2021 Versus 2025 Versus 2032
  • 1.7.2 Influenza A
  • 1.7.3 Influenza B
  • 1.7.4 Others
• 1.8 Global Masiroxavir Tablets Market Size & Forecast
  • 1.8.1 Global Masiroxavir Tablets Consumption Value (2021 & 2025 & 2032)
  • 1.8.2 Global Masiroxavir Tablets Sales Quantity (2021-2032)
  • 1.8.3 Global Masiroxavir Tablets Average Price (2021-2032)

2 Manufacturers Profiles

• 2.1 Shionogi & Co.
  • 2.1.1 Shionogi & Co. Details
  • 2.1.2 Shionogi & Co. Major Business
  • 2.1.3 Shionogi & Co. Masiroxavir Tablets Product and Services
  • 2.1.4 Shionogi & Co. Masiroxavir Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.1.5 Shionogi & Co. Recent Developments/Updates
• 2.2 Roche
  • 2.2.1 Roche Details
  • 2.2.2 Roche Major Business
  • 2.2.3 Roche Masiroxavir Tablets Product and Services
  • 2.2.4 Roche Masiroxavir Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.2.5 Roche Recent Developments/Updates

3 Competitive Environment: Masiroxavir Tablets by Manufacturer

• 3.1 Global Masiroxavir Tablets Sales Quantity by Manufacturer (2021-2026)
• 3.2 Global Masiroxavir Tablets Revenue by Manufacturer (2021-2026)
• 3.3 Global Masiroxavir Tablets Average Price by Manufacturer (2021-2026)
• 3.4 Market Share Analysis (2025)
  • 3.4.1 Producer Shipments of Masiroxavir Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2025
  • 3.4.2 Top 3 Masiroxavir Tablets Manufacturer Market Share in 2025
  • 3.4.3 Top 6 Masiroxavir Tablets Manufacturer Market Share in 2025
• 3.5 Masiroxavir Tablets Market: Overall Company Footprint Analysis
  • 3.5.1 Masiroxavir Tablets Market: Region Footprint
  • 3.5.2 Masiroxavir Tablets Market: Company Product Type Footprint
  • 3.5.3 Masiroxavir Tablets Market: Company Product Application Footprint
• 3.6 New Market Entrants and Barriers to Market Entry
• 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

• 4.1 Global Masiroxavir Tablets Market Size by Region
  • 4.1.1 Global Masiroxavir Tablets Sales Quantity by Region (2021-2032)
  • 4.1.2 Global Masiroxavir Tablets Consumption Value by Region (2021-2032)
  • 4.1.3 Global Masiroxavir Tablets Average Price by Region (2021-2032)
• 4.2 North America Masiroxavir Tablets Consumption Value (2021-2032)
• 4.3 Europe Masiroxavir Tablets Consumption Value (2021-2032)
• 4.4 Asia-Pacific Masiroxavir Tablets Consumption Value (2021-2032)
• 4.5 South America Masiroxavir Tablets Consumption Value (2021-2032)
• 4.6 Middle East & Africa Masiroxavir Tablets Consumption Value (2021-2032)

5 Market Segment by Type

• 5.1 Global Masiroxavir Tablets Sales Quantity by Type (2021-2032)
• 5.2 Global Masiroxavir Tablets Consumption Value by Type (2021-2032)
• 5.3 Global Masiroxavir Tablets Average Price by Type (2021-2032)

6 Market Segment by Application

• 6.1 Global Masiroxavir Tablets Sales Quantity by Application (2021-2032)
• 6.2 Global Masiroxavir Tablets Consumption Value by Application (2021-2032)
• 6.3 Global Masiroxavir Tablets Average Price by Application (2021-2032)

7 North America

• 7.1 North America Masiroxavir Tablets Sales Quantity by Type (2021-2032)
• 7.2 North America Masiroxavir Tablets Sales Quantity by Application (2021-2032)
• 7.3 North America Masiroxavir Tablets Market Size by Country
  • 7.3.1 North America Masiroxavir Tablets Sales Quantity by Country (2021-2032)
  • 7.3.2 North America Masiroxavir Tablets Consumption Value by Country (2021-2032)
  • 7.3.3 United States Market Size and Forecast (2021-2032)
  • 7.3.4 Canada Market Size and Forecast (2021-2032)
  • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

• 8.1 Europe Masiroxavir Tablets Sales Quantity by Type (2021-2032)
• 8.2 Europe Masiroxavir Tablets Sales Quantity by Application (2021-2032)
• 8.3 Europe Masiroxavir Tablets Market Size by Country
  • 8.3.1 Europe Masiroxavir Tablets Sales Quantity by Country (2021-2032)
  • 8.3.2 Europe Masiroxavir Tablets Consumption Value by Country (2021-2032)
  • 8.3.3 Germany Market Size and Forecast (2021-2032)
  • 8.3.4 France Market Size and Forecast (2021-2032)
  • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
  • 8.3.6 Russia Market Size and Forecast (2021-2032)
  • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

• 9.1 Asia-Pacific Masiroxavir Tablets Sales Quantity by Type (2021-2032)
• 9.2 Asia-Pacific Masiroxavir Tablets Sales Quantity by Application (2021-2032)
• 9.3 Asia-Pacific Masiroxavir Tablets Market Size by Region
  • 9.3.1 Asia-Pacific Masiroxavir Tablets Sales Quantity by Region (2021-2032)
  • 9.3.2 Asia-Pacific Masiroxavir Tablets Consumption Value by Region (2021-2032)
  • 9.3.3 China Market Size and Forecast (2021-2032)
  • 9.3.4 Japan Market Size and Forecast (2021-2032)
  • 9.3.5 South Korea Market Size and Forecast (2021-2032)
  • 9.3.6 India Market Size and Forecast (2021-2032)
  • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
  • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

• 10.1 South America Masiroxavir Tablets Sales Quantity by Type (2021-2032)
• 10.2 South America Masiroxavir Tablets Sales Quantity by Application (2021-2032)
• 10.3 South America Masiroxavir Tablets Market Size by Country
  • 10.3.1 South America Masiroxavir Tablets Sales Quantity by Country (2021-2032)
  • 10.3.2 South America Masiroxavir Tablets Consumption Value by Country (2021-2032)
  • 10.3.3 Brazil Market Size and Forecast (2021-2032)
  • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

• 11.1 Middle East & Africa Masiroxavir Tablets Sales Quantity by Type (2021-2032)
• 11.2 Middle East & Africa Masiroxavir Tablets Sales Quantity by Application (2021-2032)
• 11.3 Middle East & Africa Masiroxavir Tablets Market Size by Country
  • 11.3.1 Middle East & Africa Masiroxavir Tablets Sales Quantity by Country (2021-2032)
  • 11.3.2 Middle East & Africa Masiroxavir Tablets Consumption Value by Country (2021-2032)
  • 11.3.3 Turkey Market Size and Forecast (2021-2032)
  • 11.3.4 Egypt Market Size and Forecast (2021-2032)
  • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
  • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

• 12.1 Masiroxavir Tablets Market Drivers
• 12.2 Masiroxavir Tablets Market Restraints
• 12.3 Masiroxavir Tablets Trends Analysis
• 12.4 Porters Five Forces Analysis
  • 12.4.1 Threat of New Entrants
  • 12.4.2 Bargaining Power of Suppliers
  • 12.4.3 Bargaining Power of Buyers
  • 12.4.4 Threat of Substitutes
  • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

• 13.1 Raw Material of Masiroxavir Tablets and Key Manufacturers
• 13.2 Manufacturing Costs Percentage of Masiroxavir Tablets
• 13.3 Masiroxavir Tablets Production Process
• 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

• 14.1 Sales Channel
  • 14.1.1 Direct to End-User
  • 14.1.2 Distributors
• 14.2 Masiroxavir Tablets Typical Distributors
• 14.3 Masiroxavir Tablets Typical Customers

15 Research Findings and Conclusion

16 Appendix

• 16.1 Methodology
• 16.2 Research Process and Data Source

According to our (Global Info Research) latest study, the global Masiroxavir Tablets market size was valued at US$ 115 million in 2025 and is forecast to a readjusted size of US$ 815 million by 2032 with a CAGR of 35.2% during review period.
Baloxavir Marboxil Tablets is a new, oral, single-dose anti-influenza virus drug belonging to cap-dependent endonuclease inhibitors. It exerts its effect by inhibiting influenza virus gene replication, which can rapidly eliminate the virus, shorten the course of disease, and reduce infectivity. Clinically, it is mainly used for the treatment of influenza A and B in people aged 12 years and older. It features rapid onset, convenient administration, and good tolerability, and is currently a first-line targeted anti-influenza drug in clinical practice.In 2025, global production of Baloxavir Marboxil Tablets reached approximately 120 million tablets
As a new-generation anti-influenza drug, Baloxavir Marboxil Tablets (Xofluza) has rapidly become an important player in the global anti-influenza market relying on its core advantages of single oral dose, rapid onset and high compliance. Its unique cap-dependent endonuclease inhibition mechanism can block virus proliferation at the early stage of replication and significantly shorten the course of disease and infectious period. In the Chinese market, the drug has achieved rapid growth since its approval in 2021, and its accessibility has been significantly improved through medical insurance access, occupying a mainstream position in the high-end anti-influenza segment. With the successive launch of domestic generic drugs and innovative drugs, market competition has intensified, and the market will present a tripartite pattern of imported original drugs, domestic generic drugs and domestic innovative drugs in the future. Meanwhile, drug resistance risk and medical insurance cost control will become key factors affecting its long-term market development.
This report is a detailed and comprehensive analysis for global Masiroxavir Tablets market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Masiroxavir Tablets market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Masiroxavir Tablets market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Masiroxavir Tablets market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Masiroxavir Tablets market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Masiroxavir Tablets
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Masiroxavir Tablets market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Shionogi & Co., Roche, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Masiroxavir Tablets market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
20 mg per tablet
40 mg per tablet
Market segment by Target Population
Patients Aged 12 Years And Older With Influenza A
Patients Aged 12 Years And Older With Influenza B
Market segment by Sales Channels
Hospital
Retail
Online
Market segment by Production Technology
Innovator
Generic
Market segment by Application
Influenza A
Influenza B
Others
Major players covered
Shionogi & Co.
Roche
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Masiroxavir Tablets product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Masiroxavir Tablets, with price, sales quantity, revenue, and global market share of Masiroxavir Tablets from 2021 to 2026.
Chapter 3, the Masiroxavir Tablets competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Masiroxavir Tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Masiroxavir Tablets market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Masiroxavir Tablets.
Chapter 14 and 15, to describe Masiroxavir Tablets sales channel, distributors, customers, research findings and conclusion.